Highest-materiality recent filing
YourSpace terminated share exchange agreement on Oct 28, 2024, failing to provide audited 2023 financials.
Nu-Med Plus completes acquisition of YourSpace America, new CEO and majority control shift
Nu-Med Plus acquires YourSpace America via share exchange; YSA becomes wholly owned subsidiary as of April 28, 2024.
Nu-Med Plus to merge with YourSpace America; YSA's Colvin to become CEO with majority voting control
4,500,000 Series A Preferred shares (20:1 voting, convertible into 20 common each) issued to YSA shareholders at closing.
On October 28, 2024, the Board of Directors appointed Mr. William Hayde, who is the Chairman of the Board, to serve as President/Chief Executive Officer of Nu-Med.
Mr. Colvin submitted his resignation from the positions to which he had been appointed.
Following the appointment of Mr. Colvin as President and Chief Executive Officer, the Company’s former President and CEO William Hayde was appointed to serve as the Company’s Executive Chairman of the Board.
the Board of Directors of the Company appointed William R. “Russ” Colvin as the Company’s President, Chief Executive Officer, and Director of the Company.
Max materiality 0.90 · Median 0.85 · Most common event m_and_a